Market Cap 252.21M
Revenue (ttm) 4.90M
Net Income (ttm) -173.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,546.94%
Debt to Equity Ratio -0.28
Volume 356,100
Avg Vol 77,632
Day's Range N/A - N/A
Shares Out 36.71M
Stochastic %K 59%
Beta 1.21
Analysts Strong Sell
Price Target $17.50

Company Profile

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 665 2928
Fax: 310 665 2963
Address:
5005 McConnell Avenue, Los Angeles, United States
prismmarketview
prismmarketview Jun. 23 at 8:32 PM
$ARMP received an additional $2.5 million in non-dilutive funding from the U.S. Department of Defense, raising its total award to $28.7 million to support Phase 3 readiness of its lead bacteriophage clinical candidate, AP-SA02. https://prismmarketview.com/companies/armata-pharmaceuticals-inc/
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 23 at 12:39 PM
$ARMP (+11.4% pre) Armata gets $2.5M more in DoD funding for bacteriophage drug https://ooc.bz/l/105849
0 · Reply
focafoca99
focafoca99 Jun. 16 at 9:23 PM
$ARMP elected seven directors at its June 11 annual meeting and ratified Ernst & Young as auditor.
0 · Reply
SCHDeeZnutZ
SCHDeeZnutZ Jun. 3 at 11:59 PM
$ARMP if they end up needing to dilute and drive down the share price below $5, I’ll buy back in.
1 · Reply
Thalassophile
Thalassophile May. 18 at 2:11 PM
$ARMP 14% interest in that loan may be a bridge too far for investors
1 · Reply
All4Retiring
All4Retiring May. 14 at 12:52 AM
Investor Relations - 0001104659-26-060384 - SCHEDULE 13D/A - Innoviva $ARMP It appears INVA loans Armata money https://investor.inva.com/sec-filings/sec-filing/schedule-13da/0001104659-26-060384
0 · Reply
Thalassophile
Thalassophile May. 12 at 1:44 PM
$ARMP If this continues to follow the charting pattern of the last year, next leg will get close to 15
1 · Reply
Trapped
Trapped May. 7 at 6:43 PM
$ARMP this can go back to 11 in a heartbeat.
0 · Reply
Thalassophile
Thalassophile May. 7 at 4:24 PM
$ARMP boy did I time this wrong
0 · Reply
All_City_Baby
All_City_Baby May. 7 at 11:53 AM
$ARMP Fast Track Designation announced this morning. https://www.prnewswire.com/news-releases/armata-pharmaceuticals-secures-fda-fast-track-designation-for-ap-sa02-302764421.html
0 · Reply
Latest News on ARMP
Armata Pharmaceuticals Slides: Corporate presentation

Jun 11, 2026, 7:00 AM EDT - 13 days ago

Armata Pharmaceuticals Slides: Corporate presentation


Armata Pharmaceuticals Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 weeks ago

Armata Pharmaceuticals Quarterly report: Q1 2026


Armata Pharmaceuticals Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 weeks ago

Armata Pharmaceuticals Earnings release: Q1 2026


Armata Pharmaceuticals Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Armata Pharmaceuticals Proxy statement: Proxy filing


Armata Pharmaceuticals Annual report: Q4 2025

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Armata Pharmaceuticals Annual report: Q4 2025


Armata Pharmaceuticals Earnings release: Q4 2025

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Armata Pharmaceuticals Earnings release: Q4 2025


Armata Pharmaceuticals delays announcement of Q4, FY25 results

2026-03-19T11:15:28.000Z - 3 months ago

Armata Pharmaceuticals delays announcement of Q4, FY25 results


Armata price target raised to $15 from $9 at H.C. Wainwright

2026-02-23T14:38:12.000Z - 4 months ago

Armata price target raised to $15 from $9 at H.C. Wainwright


Armata Pharmaceuticals initiated with a Buy at JonesResearch

2026-01-05T12:15:27.000Z - 6 months ago

Armata Pharmaceuticals initiated with a Buy at JonesResearch


Armata Pharmaceuticals reports Q3 EPS (74c) vs. (15c) last year

2025-11-12T21:10:57.000Z - 8 months ago

Armata Pharmaceuticals reports Q3 EPS (74c) vs. (15c) last year


Armata Pharmaceuticals Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Armata Pharmaceuticals Quarterly report: Q3 2025


Armata Pharmaceuticals Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Armata Pharmaceuticals Earnings release: Q3 2025


Armata Pharmaceuticals trading resumes

2025-11-10T15:15:34.000Z - 8 months ago

Armata Pharmaceuticals trading resumes


Armata Pharmaceuticals trading halted, volatility trading pause

2025-11-10T15:11:07.000Z - 8 months ago

Armata Pharmaceuticals trading halted, volatility trading pause


Armata Pharmaceuticals trading resumes

2025-10-22T15:30:10.000Z - 8 months ago

Armata Pharmaceuticals trading resumes


Armata Pharmaceuticals trading halted, news pending

2025-10-22T14:35:09.000Z - 8 months ago

Armata Pharmaceuticals trading halted, news pending


Armata Pharmaceuticals Slides: Investor presentation

Oct 22, 2025, 7:00 AM EDT - 8 months ago

Armata Pharmaceuticals Slides: Investor presentation


Armata Pharmaceuticals Slides: Investor presentation

Sep 10, 2025, 7:00 AM EDT - 10 months ago

Armata Pharmaceuticals Slides: Investor presentation


Armata Pharmaceuticals Registration statement: Registration filing

Aug 13, 2025, 8:00 AM EDT - 11 months ago

Armata Pharmaceuticals Registration statement: Registration filing


Armata Pharmaceuticals Quarterly report: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Armata Pharmaceuticals Quarterly report: Q2 2025


Armata Pharmaceuticals Earnings release: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Armata Pharmaceuticals Earnings release: Q2 2025


Armata Pharmaceuticals Quarterly report: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Armata Pharmaceuticals Quarterly report: Q1 2025


Armata Pharmaceuticals Earnings release: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Armata Pharmaceuticals Earnings release: Q1 2025


Armata Pharmaceuticals Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Armata Pharmaceuticals Proxy statement: Proxy filing


Armata Pharmaceuticals Annual report: Q4 2024

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Armata Pharmaceuticals Annual report: Q4 2024


Armata Pharmaceuticals Earnings release: Q4 2024

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Armata Pharmaceuticals Earnings release: Q4 2024


Armata Pharmaceuticals Quarterly report: Q3 2024

Nov 13, 2024, 7:00 AM EST - 1 year ago

Armata Pharmaceuticals Quarterly report: Q3 2024


Armata Pharmaceuticals Earnings release: Q3 2024

Nov 13, 2024, 7:00 AM EST - 1 year ago

Armata Pharmaceuticals Earnings release: Q3 2024


Armata Pharmaceuticals Quarterly report: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Quarterly report: Q2 2024


Armata Pharmaceuticals Earnings release: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Earnings release: Q2 2024


Armata Pharmaceuticals Quarterly report: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Quarterly report: Q1 2024


Armata Pharmaceuticals Earnings release: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Earnings release: Q1 2024


Armata Pharmaceuticals Proxy statement: Proxy filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Proxy statement: Proxy filing


Armata Pharmaceuticals Annual report: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Annual report: Q4 2023


Armata Pharmaceuticals Earnings release: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Armata Pharmaceuticals Earnings release: Q4 2023


Armata Pharmaceuticals Quarterly report: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Armata Pharmaceuticals Quarterly report: Q3 2023


Armata Pharmaceuticals Earnings release: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Armata Pharmaceuticals Earnings release: Q3 2023


Armata Pharmaceuticals Quarterly report: Q2 2023

Aug 14, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Quarterly report: Q2 2023


Armata Pharmaceuticals Earnings release: Q2 2023

Aug 14, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Earnings release: Q2 2023


Armata Pharmaceuticals Proxy statement: Proxy filing

Aug 3, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Proxy statement: Proxy filing


Armata Pharmaceuticals Proxy statement: Proxy filing

Aug 3, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Proxy statement: Proxy filing


Armata Pharmaceuticals Proxy statement: Proxy filing

Jul 24, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Proxy statement: Proxy filing


Armata Pharmaceuticals Quarterly report: Q1 2023

May 11, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Quarterly report: Q1 2023


Armata Pharmaceuticals Earnings release: Q1 2023

May 11, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Earnings release: Q1 2023


Armata Pharmaceuticals Annual report: Q4 2022

Mar 16, 2023, 8:00 AM EDT - 3 years ago

Armata Pharmaceuticals Annual report: Q4 2022


prismmarketview
prismmarketview Jun. 23 at 8:32 PM
$ARMP received an additional $2.5 million in non-dilutive funding from the U.S. Department of Defense, raising its total award to $28.7 million to support Phase 3 readiness of its lead bacteriophage clinical candidate, AP-SA02. https://prismmarketview.com/companies/armata-pharmaceuticals-inc/
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 23 at 12:39 PM
$ARMP (+11.4% pre) Armata gets $2.5M more in DoD funding for bacteriophage drug https://ooc.bz/l/105849
0 · Reply
focafoca99
focafoca99 Jun. 16 at 9:23 PM
$ARMP elected seven directors at its June 11 annual meeting and ratified Ernst & Young as auditor.
0 · Reply
SCHDeeZnutZ
SCHDeeZnutZ Jun. 3 at 11:59 PM
$ARMP if they end up needing to dilute and drive down the share price below $5, I’ll buy back in.
1 · Reply
Thalassophile
Thalassophile May. 18 at 2:11 PM
$ARMP 14% interest in that loan may be a bridge too far for investors
1 · Reply
All4Retiring
All4Retiring May. 14 at 12:52 AM
Investor Relations - 0001104659-26-060384 - SCHEDULE 13D/A - Innoviva $ARMP It appears INVA loans Armata money https://investor.inva.com/sec-filings/sec-filing/schedule-13da/0001104659-26-060384
0 · Reply
Thalassophile
Thalassophile May. 12 at 1:44 PM
$ARMP If this continues to follow the charting pattern of the last year, next leg will get close to 15
1 · Reply
Trapped
Trapped May. 7 at 6:43 PM
$ARMP this can go back to 11 in a heartbeat.
0 · Reply
Thalassophile
Thalassophile May. 7 at 4:24 PM
$ARMP boy did I time this wrong
0 · Reply
All_City_Baby
All_City_Baby May. 7 at 11:53 AM
$ARMP Fast Track Designation announced this morning. https://www.prnewswire.com/news-releases/armata-pharmaceuticals-secures-fda-fast-track-designation-for-ap-sa02-302764421.html
0 · Reply
chefETank
chefETank May. 7 at 1:41 AM
$ARMP might want to put some in ocgn while waiting for this
0 · Reply
Trapped
Trapped May. 6 at 4:14 PM
$ARMP undervalued
0 · Reply
Thalassophile
Thalassophile May. 6 at 1:42 PM
$ARMP next leg coming
0 · Reply
LewisDaKat
LewisDaKat May. 4 at 5:30 PM
$ARMP Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" https://marketwirenews.com/stock/armp/news/armata-pharmaceuticals-announces-structural-biology--7253516350848090.html?utm_source=stocktwits
0 · Reply
Trapped
Trapped May. 3 at 1:07 PM
$ARMP this is loading territory….
0 · Reply
History101
History101 May. 1 at 11:02 PM
$ARMP anyone know why ARMP dropped 39.9% (From $14.80 on Apr 21 to $8.89 now) in 8 trading days?
1 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 10:34 PM
$ARMP Share Price: $8.89 Contract Selected: Nov 20, 2026 $12.5 Calls Buy Zone: $0.09 – $0.11 Target Zone: $0.15 – $0.18 Potential Upside: 63% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Thalassophile
Thalassophile May. 1 at 6:52 PM
$ARMP Next leg up coming Monday?
0 · Reply
All_City_Baby
All_City_Baby May. 1 at 4:41 PM
$ARMP I'm hoping for news of Fast Track status for their Staph Aureus bacteriophage drug candidate in the next two weeks.
0 · Reply
Thalassophile
Thalassophile Apr. 27 at 5:43 PM
$ARMP just bought a block at 11.40 😅 your welcome
0 · Reply
Paytient
Paytient Apr. 27 at 2:52 PM
$ARMP what the !?!
0 · Reply
Trapped
Trapped Apr. 22 at 10:34 AM
$ARMP 457 million market cap!!!! way way toooo low!!! worth billions. going to $50
0 · Reply